标题
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-08-30
DOI
10.3389/fimmu.2022.955035
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report
- (2022) Mariateresa Cantelli et al. Dermatologic Therapy
- Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
- (2022) Steven R. Ytterberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
- (2022) Daniela Mikhaylov et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Successful treatment of chronic severe alopecia areata with abrocitinib
- (2022) Michaela Bennett et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- The current state of knowledge of the immune ecosystem in alopecia areata
- (2022) Samuel J. Connell et al. AUTOIMMUNITY REVIEWS
- Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study
- (2022) Simon de Lusignan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata
- (2022) Brett King et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- (2022) Brett King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
- (2022) Léa Hoisnard et al. Scientific Reports
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- (2021) Brett King et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Blockade of IL-7 signaling suppresses inflammatory responses and reverses alopecia areata in C3H/HeJ mice
- (2021) Zhenpeng Dai et al. Science Advances
- Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies
- (2021) Inge Lodewijckx et al. Pharmaceuticals
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- (2021) Özge Aşkın et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata
- (2021) Alessio Gambardella et al. Dermatitis
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- (2021) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- (2021) Brett King et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hair follicle immune privilege and its collapse in alopecia areata
- (2020) Marta Bertolini et al. EXPERIMENTAL DERMATOLOGY
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- (2020) Jung Eun Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Factors associated with insurance coverage of tofacitinib for alopecia areata: a retrospective review from an academic institution
- (2020) Hannah J. Thompson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Increased Serum Levels of IFN-γ, IL-1β, and IL-6 in Patients with Alopecia Areata and Nonsegmental Vitiligo
- (2020) Katarzyna Tomaszewska et al. Oxidative Medicine and Cellular Longevity
- Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases
- (2020) Sailish Honap et al. INFLAMMATORY BOWEL DISEASES
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- (2020) Rebekka Jerjen et al. PEDIATRIC DERMATOLOGY
- JAK inhibitors and alopecia areata
- (2019) Amos Gilhar et al. LANCET
- PF-06651600, a dual JAK3/TEC family kinase inhibitor
- (2019) Hua Xu et al. ACS Chemical Biology
- Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study
- (2019) Elise A. Olsen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- (2018) A. Jabbari et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases
- (2018) Michael L. Vazquez et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- (2018) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study
- (2018) Laita Bokhari et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)
- (2018) Andrew Fensome et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tofacitinib for the Treatment of Alopecia Areata in Preadolescent Children
- (2018) Brittany G. Craiglow et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ruxolitinib for the treatment of severe alopecia areata
- (2018) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma
- (2018) Jung-Min Shin et al. Scientific Reports
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- (2017) Amy Vandiver et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis
- (2017) Christopher Banfield et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- (2017) Cheryl B. Bayart et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hypertriglyceridaemia and risk of coronary artery disease
- (2017) Željko Reiner Nature Reviews Cardiology
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
- (2016) Jean-Baptiste Telliez et al. ACS Chemical Biology
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- (2016) Ali Jabbari et al. EXPERIMENTAL DERMATOLOGY
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- (2016) John E. Harris et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata
- (2015) Xiaoting Zhang et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy
- (2015) Jianbao Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transfer of Alopecia Areata to C3H/HeJ Mice Using Cultured Lymph Node–Derived Cells
- (2015) Eddy H.C. Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Quality of life in patients with alopecia areata: a hospital-based cross-sectional study
- (2015) S. Janković et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- (2015) Ali Jabbari et al. EBioMedicine
- Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer
- (2014) A. Mishra et al. CLINICAL CANCER RESEARCH
- Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo
- (2014) Atsuo Tanimoto et al. INFLAMMATION RESEARCH
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- (2014) Brittany G. Craiglow et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- (2014) Luzhou Xing et al. NATURE MEDICINE
- The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders
- (2013) Yasuko Furumoto et al. BIODRUGS
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages
- (2011) Wei Liao et al. NATURE IMMUNOLOGY
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
- (2010) Thomas R. Malek et al. IMMUNITY
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- (2010) Lynn Petukhova et al. NATURE
- Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy
- (2009) N. Barahmani et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
- (2009) Xiaoyu Hu et al. IMMUNITY
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
- Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
- (2007) Taisuke Ito et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started